Ngenla™ (somatrogon-ghla) – New orphan drug approval
June 28, 2023 - Pfizer announced the FDA approval of Ngenla (somatrogon-ghla), for the treatment of pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of endogenous growth hormone.
Download PDF
